EGFR mutation analysis detects acquired mutations in the EGFR gene in tumor specimens of patients with NSCLC.  There are various polymerase chain reaction (PCR)-methods that can detect the mutations, as well as through the use of direct sequencing, which is currently considered the gold standard. The gene discussed is EGFR; the disease is neoplasm.